BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

308 related articles for article (PubMed ID: 19427061)

  • 1. Sex difference in pathology and memory decline in rTg4510 mouse model of tauopathy.
    Yue M; Hanna A; Wilson J; Roder H; Janus C
    Neurobiol Aging; 2011 Apr; 32(4):590-603. PubMed ID: 19427061
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel transgenic mouse expressing double mutant tau driven by its natural promoter exhibits tauopathy characteristics.
    Rosenmann H; Grigoriadis N; Eldar-Levy H; Avital A; Rozenstein L; Touloumi O; Behar L; Ben-Hur T; Avraham Y; Berry E; Segal M; Ginzburg I; Abramsky O
    Exp Neurol; 2008 Jul; 212(1):71-84. PubMed ID: 18490011
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hippocampal tauopathy in tau transgenic mice coincides with impaired hippocampus-dependent learning and memory, and attenuated late-phase long-term depression of synaptic transmission.
    Van der Jeugd A; Ahmed T; Burnouf S; Belarbi K; Hamdame M; Grosjean ME; Humez S; Balschun D; Blum D; Buée L; D'Hooge R
    Neurobiol Learn Mem; 2011 Mar; 95(3):296-304. PubMed ID: 21167950
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 3R tau expression modifies behavior in transgenic mice.
    Shiryaev N; Jouroukhin Y; Gozes I
    J Neurosci Res; 2010 Sep; 88(12):2727-35. PubMed ID: 20544828
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential regional distribution of phosphorylated tau and synapse loss in the nucleus accumbens in tauopathy model mice.
    Kambe T; Motoi Y; Inoue R; Kojima N; Tada N; Kimura T; Sahara N; Yamashita S; Mizoroki T; Takashima A; Shimada K; Ishiguro K; Mizuma H; Onoe H; Mizuno Y; Hattori N
    Neurobiol Dis; 2011 Jun; 42(3):404-14. PubMed ID: 21324362
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early depletion of CA1 neurons and late neurodegeneration in a mouse tauopathy model.
    Helboe L; Egebjerg J; Barkholt P; Volbracht C
    Brain Res; 2017 Jun; 1665():22-35. PubMed ID: 28411086
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Volumetric MRI and MRS provide sensitive measures of Alzheimer's disease neuropathology in inducible Tau transgenic mice (rTg4510).
    Yang D; Xie Z; Stephenson D; Morton D; Hicks CD; Brown TM; Sriram R; O'Neill S; Raunig D; Bocan T
    Neuroimage; 2011 Feb; 54(4):2652-8. PubMed ID: 21035554
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early intervention of tau pathology prevents behavioral changes in the rTg4510 mouse model of tauopathy.
    Wang X; Smith K; Pearson M; Hughes A; Cosden ML; Marcus J; Hess JF; Savage MJ; Rosahl T; Smith SM; Schachter JB; Uslaner JM
    PLoS One; 2018; 13(4):e0195486. PubMed ID: 29624602
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sodium selenate specifically activates PP2A phosphatase, dephosphorylates tau and reverses memory deficits in an Alzheimer's disease model.
    Corcoran NM; Martin D; Hutter-Paier B; Windisch M; Nguyen T; Nheu L; Sundstrom LE; Costello AJ; Hovens CM
    J Clin Neurosci; 2010 Aug; 17(8):1025-33. PubMed ID: 20537899
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 'Prion-like' propagation of mouse and human tau aggregates in an inducible mouse model of tauopathy.
    Sydow A; Mandelkow EM
    Neurodegener Dis; 2010; 7(1-3):28-31. PubMed ID: 20160454
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Elevated levels of soluble total and hyperphosphorylated tau result in early behavioral deficits and distinct changes in brain pathology in a new tau transgenic mouse model.
    Flunkert S; Hierzer M; Löffler T; Rabl R; Neddens J; Duller S; Schofield EL; Ward MA; Posch M; Jungwirth H; Windisch M; Hutter-Paier B
    Neurodegener Dis; 2013; 11(4):194-205. PubMed ID: 22797329
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NAP protects memory, increases soluble tau and reduces tau hyperphosphorylation in a tauopathy model.
    Shiryaev N; Jouroukhin Y; Giladi E; Polyzoidou E; Grigoriadis NC; Rosenmann H; Gozes I
    Neurobiol Dis; 2009 May; 34(2):381-8. PubMed ID: 19264130
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of the C57BL/6 strain background on tauopathy progression in the rTg4510 mouse model.
    Bailey RM; Howard J; Knight J; Sahara N; Dickson DW; Lewis J
    Mol Neurodegener; 2014 Jan; 9():8. PubMed ID: 24428919
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tracking progressive pathological and functional decline in the rTg4510 mouse model of tauopathy.
    Blackmore T; Meftah S; Murray TK; Craig PJ; Blockeel A; Phillips K; Eastwood B; O'Neill MJ; Marston H; Ahmed Z; Gilmour G; Gastambide F
    Alzheimers Res Ther; 2017 Sep; 9(1):77. PubMed ID: 28931441
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of alpha-tocopherol on an animal model of tauopathies.
    Nakashima H; Ishihara T; Yokota O; Terada S; Trojanowski JQ; Lee VM; Kuroda S
    Free Radic Biol Med; 2004 Jul; 37(2):176-86. PubMed ID: 15203189
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alzheimer's disease-like tau neuropathology leads to memory deficits and loss of functional synapses in a novel mutated tau transgenic mouse without any motor deficits.
    Schindowski K; Bretteville A; Leroy K; Bégard S; Brion JP; Hamdane M; Buée L
    Am J Pathol; 2006 Aug; 169(2):599-616. PubMed ID: 16877359
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased O-GlcNAcylation reduces pathological tau without affecting its normal phosphorylation in a mouse model of tauopathy.
    Graham DL; Gray AJ; Joyce JA; Yu D; O'Moore J; Carlson GA; Shearman MS; Dellovade TL; Hering H
    Neuropharmacology; 2014 Apr; 79():307-13. PubMed ID: 24326295
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Truncated tau expression levels determine life span of a rat model of tauopathy without causing neuronal loss or correlating with terminal neurofibrillary tangle load.
    Koson P; Zilka N; Kovac A; Kovacech B; Korenova M; Filipcik P; Novak M
    Eur J Neurosci; 2008 Jul; 28(2):239-46. PubMed ID: 18702695
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phosphorylation and oligomerization of α-synuclein associated with GSK-3β activation in the rTg4510 mouse model of tauopathy.
    Takaichi Y; Chambers JK; Inoue H; Ano Y; Takashima A; Nakayama H; Uchida K
    Acta Neuropathol Commun; 2020 Jun; 8(1):86. PubMed ID: 32560668
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hyperactivity with Agitative-Like Behavior in a Mouse Tauopathy Model.
    Jul P; Volbracht C; de Jong IE; Helboe L; Elvang AB; Pedersen JT
    J Alzheimers Dis; 2016; 49(3):783-95. PubMed ID: 26519432
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.